TEPSeUltrasound-Assisted Psoas Tenotomy for Ilio-Psoas Conflict After Hip Replacement
The study evaluates the success rate of using ultrasound-assisted psoas tenotomy to relieve ilio-psoas conflict in patients who have had hip replacement surgery.
Psoas tenotomy under ultrasound
Wounds and Injuries
+ Hip Injuries
Treatment Study
Summary
Study start date: December 1, 2025
Actual date on which the first participant was enrolled.The study focuses on finding a new way to relieve pain in people who experience discomfort after having a hip replacement. This discomfort often occurs due to a clash between the hip implant and a tendon in the body called the ilio-psoas tendon. The traditional method to relieve this pain is a procedure called psoas tenotomy, which involves cutting the tendon to ease the tension. However, this study explores the use of ultrasound technology to perform this procedure, which might offer a less invasive option with quicker recovery and fewer complications. This new method could significantly enhance the comfort and mobility of those suffering from this post-surgery complication. In this study, participants who have pain after a hip replacement due to ilio-psoas conflict will undergo an ultrasound-assisted psoas tenotomy. Instead of using more complex surgical equipment, this technique uses ultrasound to guide the procedure, which might lead to less scarring and a quicker surgical process. The study will evaluate how well this approach works by measuring pain relief and improvements in movement and function after the procedure. This could provide a safer and more efficient option for patients, potentially leading to better overall outcomes in their recovery process.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.15 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location